Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Frontiers in Molecular Biosciences|February 12, 2025
Aging, cancer, and autophagy: connections and therapeutic perspectivesBegoña Zapatería, Esperanza AriasCurrent Opinion in Cell Biology|November 25, 2010
Chaperone-mediated autophagy in protein quality controlEsperanza Arias, Ana Maria CuervoMolecular Aspects of Medicine|October 11, 2021
Chaperone-mediated autophagy and disease: Implications for cancer and neurodegenerationRaquel Gómez-Sintes, Esperanza AriasTrends in Endocrinology and Metabolism: TEM|November 9, 2019
Pros and Cons of Chaperone-Mediated Autophagy in Cancer BiologyEsperanza Arias, Ana Maria CuervoJournal of Molecular Neuroscience : MN|November 11, 2005
Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivoXinyu D Li, Esperanza Arias, Ramamohana R Jonnala, et al.The Journal of Pharmacology and Experimental Therapeutics|September 8, 2005
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptorsEsperanza Arias, Sonia Gallego-Sandín, Mercedes Villarroya, et al.Molecular Cell|June 30, 2015
Lysosomal mTORC2/PHLPP1/Akt Regulate Chaperone-Mediated AutophagyEsperanza Arias, Hiroshi Koga, Antonio Diaz, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2011
Constitutive upregulation of chaperone-mediated autophagy in Huntington's diseaseHiroshi Koga, Marta Martinez-Vicente, Esperanza Arias, et al.Autophagy|June 29, 2018
Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2AMarta Pajares, Ana I Rojo, Esperanza Arias, et al.Journal of Molecular Neuroscience : MN|December 29, 2006
Can cholinesterase inhibitors provide additional effects to cholinergic neurotransmission enhancement?Manuela G López, Esperanza Arias, Mónica Sobrado, et al.Pageof 4